Kenneth Y. Tsai, PhD, MD, FAAD
SESSIONS
No sessions scheduled for this speaker.
DISCLOSURES
3CC - Third Culture Capital – Stockholder(No Compensation Received); DX Biosciences, Inc – Consultant(Stock Options); NFlection Therapeutics, Inc – Consultant(Fees); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); Verrica Pharmaceuticals Inc – Consultant(Fees), Independent Contractor(Fees); WorldCare Clinical LLC – Independent Contractor(Fees);